Risperidone Augmentation in Patients With Schizophrenia

Summary

We propose a double-blind, placebo-controlled trial to study the effectiveness and tolerability of adding risperidone to stable yet only partially remitted patients with schizophrenia maintained on clozapine.

Timeline

Start

2003-02

Primary completion

2007-03

Completion

2007-03

Publications

• Results Freudenreich O, Henderson DC, Walsh JP, Culhane MA, Goff DC. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial. Schizophr Res. 2007 May;92(1-3):90-4. doi: 10.1016/j.schres.2006.12.030. Epub 2007 Feb 23.

Drugs

Indications